Stockscreener 앱 받기
2.36
0.42%
-0.01
시간 외 거래:
2.43
0.07
+2.97%
전일 마감가:
$2.37
열려 있는:
$2.39
하루 거래량:
1.10M
Relative Volume:
0.76
시가총액:
$258.93M
수익:
-
순이익/손실:
$-134.24M
주가수익비율:
-1.3333
EPS:
-1.77
순현금흐름:
$-121.34M
1주 성능:
-3.67%
1개월 성능:
-12.92%
6개월 성능:
-31.40%
1년 성능:
-57.01%
1일 변동 폭
$2.335
$2.4342
1주일 범위
$2.305
$2.62
52주 변동 폭
$1.285
$7.85
아넥손 Stock (ANNX) Company Profile
명칭
Annexon Inc
전화
(650)-822-5500
주소
1400 SIERRA POINT PARKWAY, BRISBANE
ANNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
2.36 | 257.83M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
아넥손 Stock (ANNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-30 | 개시 | Wells Fargo | Overweight |
| 2023-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-05-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 개시 | Jefferies | Buy |
| 2022-09-09 | 개시 | BTIG Research | Buy |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-09-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
모두보기
아넥손 주식(ANNX)의 최신 뉴스
Trend analysis for Annexon Inc. this weekTop Stock Picks with Forecast Accuracy - Newser
What makes Annexon Inc. stock price move sharplyExpert-Backed High Yield Stock Watchlist - Newser
Combining price and volume data for Annexon Inc.Free ROI Driven Equity Selection With Safety - Newser
Momentum Screeners Rank Annexon Inc. in Top 5 TodaySwing Trading Entry Signals Suggest Opportunity Zone - metal.it
Can Annexon Inc. lead its sector in growthTriple Digit Stock Opportunities - kangso.co.kr
What is Annexon Inc. s 5 year growth outlookElite Portfolio Components - mustnews.co.kr
Will Annexon Inc. stock go up soonIntraday Price Forecast Using Volume Models - Newser
Annexon, Inc. Announces vonaprument's Selection for EMA's PDC Pilot Program, Paving the Way for Potential Dry AMD Treatment Approval - Quiver Quantitative
Breakthrough Eye Drug Among 20 Selected for EMA Fast Track: Could Be First Dry AMD Treatment in Europe - Stock Titan
What makes Annexon Inc. stock attractive to long term investorsHigh Growth Low Risk Stock Selection Gets Analyst Nod - beatles.ru
What is the dividend policy of Annexon Inc. stockDiscover the fastest growing stocks today - Jammu Links News
Why is Annexon Inc. stock attracting strong analyst attentionInvest smarter with expert stock picks - Jammu Links News
Should I hold or sell Annexon Inc. stock in 2025Identify undervalued stocks ready to soar - Jammu Links News
Does Annexon Inc. stock perform well during market downturnsOver 200% growth - Jammu Links News
Is Annexon Inc. a growth stock or a value stockCapitalize on momentum-driven investment opportunities - Jammu Links News
What is Annexon Inc. company’s growth strategyAccelerated profit realization - Jammu Links News
When is Annexon Inc. stock expected to show significant growthExtraordinary earning power - Jammu Links News
What markets is CYCC expanding into Is Annexon Inc. stock a good long term investment option - Jammu Links News
Annexon Inc. Stock Analysis and ForecastSuperior capital gains - Jammu Links News
What are analysts’ price targets for Annexon Inc. in the next 12 monthsBreakthrough wealth creation - Jammu Links News
Is Annexon Inc. a Top Dividend Stock to Watch in 2025Short-Term Profit Alert With Entry Forecast - Newser
How Annexon Inc. stock performs during market volatilityFree Weekly Return Pick Forecast Reports - Newser
Signal strength of Annexon Inc. stock in tech scannersPortfolio Review Summary with Five-Year Outlook - Newser
How to forecast Annexon Inc. trends using time seriesInsider Strategy for High Conviction Picks - Newser
Carson William H. buys Annexon (ANNX) shares worth $9,999 By Investing.com - Investing.com Australia
Carson William H. buys Annexon (ANNX) shares worth $9,999 - Investing.com
Leading vs lagging indicators on Annexon Inc. performanceProven Trading System with Consistent Gains - Newser
Momentum divergence signals in Annexon Inc. chartFree High Win Rate Trading Opportunities - Newser
Huntington’s Disease Market to Expand Significantly by 2034, States DelveInsight Report | Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics - Barchart.com
Annexon (NASDAQ:ANNX) Trading 8.8% Higher – Still a Buy? - Defense World
Detecting price anomalies in Annexon Inc. with AIMachine Learning Stock Price Forecast Tool - Newser
Why did ANNX's operating profit drop sharply in Q4 2024? - AInvest
Is Annexon Inc. stock a growth or value playYearly Trend Summary and Opportunity Breakdown - Newser
Technical Heatmap Flags Annexon Inc. for WatchProfit Focused Stock Screener Results Released - beatles.ru
What are the technical indicators suggesting about Annexon Inc.Achieve rapid wealth accumulation with smart picks - Jammu Links News
아넥손 (ANNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):